LANGERHANS CELL HISTIOCYTOSIS OF THE MANDIBLE: A RARE CASE REPORT


Authors

  • Dân Nguyễn Văn Bệnh viện Quân y 175
  • Huệ Hoàng Lê Bệnh viện Quân y 175
  • Nhân Trịnh Văn Bệnh viện Quân y 175
DOI: https://doi.org/10.59354/ydth175.2024.293

Keywords:

Langerhans cell histiocytosis, mandibular

Abstract

Langerhans cell histiocytosis (LCH) is a rare disorder characterized by  the proliferation of Langerhans cells. The clinical symptoms of patients with Langerhans cell histiocytosis depend on the site and the degree of involvement.  The proportion of LCH in mandibular is reported from 10% to 20% of total LCH patients. LCH treating methods are various including the surgical curettage, the radiation therapy, the steroid injection, and the chemotherapy. LCH has a good prognosis.  Regular follow-up must be performed even after healing.

 We report the clinical case: a 42-year-old male patient was diagnosed with LCH in mandibular, treated with surgery and the steroid injection at hospital 175.

References

Dae-Seok Hwang and et (2019), “Langerhans cell histiocytosis of the mandible:

two case reports and literature review”, J Korean Assoc Oral Maxillofac Surg. 45(3):

–172.

Ardekian L, Peled M, Rosen D, and et al (1999), “Clinical and radiographic features of eosinophilic granuloma in the jaws: review of 41 lesions treated by surgery and low-dose radiotherapy”. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 87:238–242.

Guiglia R, Pizzo G, Aricò M, and et al (2009). “Bifocal manifestation of eosinophilic granuloma in a pediatric patient”. Med Sci Monit. 15:CS95–CS99.

Kim BE, Koh KN, Suh JK, and et al (2014). “Clinical features and treatment outcomes of Langerhans cell histiocytosis: a nationwide survey from Korea Histiocytosis Working Party”. J Pediatr Hematol Oncol. 36:125–133.

Badalian-Very G, Vergilio JA, Degar BA, and et al (2010). “Recurrent BRAF mutations in Langerhans cell histiocytosis”. Blood. 116:1919–1923.

Yasko AW, Fanning CV, Ayala AG, and et al (1998). “Percutaneous techniques for the diagnosis and treatment of localized Langerhans-cell histiocytosis (eosinophilic granuloma of bone)”, J Bone Joint Surg Am. 80:219–228.

Karagoz Guzey F, Bas NS, Emel E, and et al (2003). “Polyostotic monosystemic calvarial and spinal langerhans’ cell histiocytosis treated by surgery and chemotherapy”. Pediatr Neurosurg.38:206–211.

Haupt R, Minkov M, Astigarraga I, Schäfer E, and et al (2013). “Langerhans cell histiocytosis (LCH): guidelines for diagnosis, clinical work-up, and treatment for patients till the age of 18 years” . Pediatr Blood Cancer. 60:175–184.

Võ Thị Phương Mai và cộng sự (2011), “Chẩn đoán và điều trị bệnh mô bào langerhans ở trẻ em”, tạp chí Y Học TP. Hồ Chí Minh, Tập 15, 216-224.

Jan Kriz, Hans Theodor Eich, Frank Bruns and et al(2013), “Radiotherapy in langerhans cell histiocytosis - a rare indication in a rare disease”, Radiation Oncolog, 8, Article number: 233

Abstract View: 29
PDF Downloaded: 36

Published

30-09-2024

How to Cite

Nguyễn Văn , D., Hoàng Lê , H., & Trịnh Văn , N. (2024). LANGERHANS CELL HISTIOCYTOSIS OF THE MANDIBLE: A RARE CASE REPORT. Journal of 175 Practical Medicine and Pharmacy, (39), 7. https://doi.org/10.59354/ydth175.2024.293